SCHEMBL13951742

SCHEMBL13951742

Cc1cccc2c1N1c3c(cccc3N(C)C1C)O2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NISCH Q9Y2I1 1/20 0.32
▸ P2RX4 Q99571 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HBB P68871 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13969348 0.83 KDM4E (0.42) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL13875974 0.76 ALDH1A1 (0.39) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL21361134 0.74 TSHR (0.41) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL13969349 0.71 NISCH (0.34) ALDH1A1NISCHMEN1KMT2APOLB
SCHEMBL22198907 0.69 KDM4E (0.35) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL19774464 0.69 KDM4E (0.33) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL11995104 0.68 ALDH1A1 (0.42) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL12349380 0.68 ALDH1A1 (0.42) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL9891023 0.68 ALDH1A1 (0.42) ALDH1A1KDM4EGAAHPGDALOX12
SCHEMBL17952165 0.68 KDM4E (0.34) ALDH1A1KDM4EGAAHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877937-B2 Process for preparing transition metal-carbene complexes BASF SE (DE) 2014-11-04 — — US disclosed
US-20130178621-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2013-07-11 — — US disclosed
US-8383828-B2 Transition metal complexes comprising one noncarbene ligand and one or two carbene ligands and their use in OLEDs BASF AKTIENGESELLSCHAFT (DE) 2013-02-26 — — US disclosed
US-20090054657-A1 Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds BASF SE (DE) 2009-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178621-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES AP1M1, C1S, GPS1 ALDH1A1 2893/4885KDM4E 4586/4885GAA 1372/4885
US-20090054657-A1 Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds OCIAD1, OCIAD2, ICOSLG ALDH1A1 1163/4885KDM4E 4609/4885GAA 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback